ImpediMed (IPD) News Today → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free IPD Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative March 14, 2024 | finance.yahoo.comImpediMed's (ASX:IPD) investors will be pleased with their notable 72% return over the last yearMarch 11, 2024 | msn.comSkin in the game: Which ASX director is betting on a lithium recovery?February 26, 2024 | benzinga.comImpedimed Stock (OTC:IPDQF) Dividends: History, Yield and DatesFebruary 20, 2024 | msn.comHow the experts are investing in healthcare-related AI and biotechFebruary 16, 2024 | msn.comScoPo’s Powerplays: ASX health stocks tumble as CSL bleeds after Phase III trial misses endpointFebruary 3, 2024 | morningstar.comImpedimed Ltd IPDNovember 19, 2023 | msn.comMarket Highlights: Wall Street sentiment remains high, 9 most innovative firms, and 5 small caps to watch todayNovember 19, 2023 | fool.com.au2 ASX All Ords shares tumbling following leadership shakeupsNovember 3, 2023 | msn.comScoPo’s Powerplays: Who fancies 22 minutes of exercise? And ASX health stocks are up (finally)October 21, 2023 | afr.comImpediMed LimitedOctober 6, 2023 | finance.yahoo.comInvesting in ImpediMed (ASX:IPD) a year ago would have delivered you a 146% gainSeptember 1, 2023 | finance.yahoo.comAnalysts Expect Breakeven For ImpediMed Limited (ASX:IPD) Before LongAugust 29, 2023 | finance.yahoo.comThe IPD Group Limited (ASX:IPG) Annual Results Are Out And Analysts Have Published New ForecastsJuly 17, 2023 | finance.yahoo.comHere's Why We're Watching ImpediMed's (ASX:IPD) Cash Burn SituationJuly 13, 2023 | finance.yahoo.comIPD.AX - ImpediMed LimitedJuly 12, 2023 | au.finance.yahoo.comIPD.XA - ImpediMed LimitedJune 30, 2023 | msn.comScoPo’s (actually Wilkie’s) Powerplays: Inoviq soars on clinical data for breast cancer testMay 26, 2023 | msn.comScoPo’s Powerplays: ASX health stocks fall as investors fail to reward good newsApril 22, 2023 | msn.comWILSONS Maintains ImpediMed (ASX:IPD) Overweight RecommendationApril 21, 2023 | msn.comScoPo’s (actually Iain’s) Powerplays: ASX health stocks fall, Neuren’s DAYBUE drug officially rolling out in USApril 7, 2023 | finance.yahoo.comImpediMed (ASX:IPD) shareholders have earned a 40% CAGR over the last three yearsMarch 31, 2023 | msn.comScoPo’s Powerplays: ASX health stocks rise, ImpediMed surges 99% on NCCN guidelines updateMarch 27, 2023 | msn.comGuess which ASX biotech share just rocketed 86% on ‘a major validating moment’March 26, 2023 | msn.comASX Small Caps Lunch Wrap: Who else is having trouble believing their eyes this morning?March 26, 2023 | msn.comTop 10 at 10: Cancer fighters, new lithium leaders, and a lucrative takeover offerMarch 26, 2023 | msn.comASX Health Stocks: ImpediMed pops over 60pc after BIS technology named in new US guidelinesFebruary 25, 2023 | finance.yahoo.comImpediMed First Half 2023 Earnings: AU$0.01 loss per share (vs AU$0.006 loss in 1H 2022)February 6, 2023 | finance.yahoo.comWill ImpediMed (ASX:IPD) Spend Its Cash Wisely?December 15, 2022 | finance.yahoo.comNew Data Presented at the 2022 San Antonio Breast Cancer Symposium Shows Early Detection using L-Dex and Intervention Improves Lymphedema Progression-Free SurvivalNovember 16, 2022 | finance.yahoo.comImpediMed Extends Contract for AstraZeneca for Use of the SOZO Digital Health Platform in Clinical Trial of Patients with Chronic Kidney DiseaseNovember 2, 2022 | finance.yahoo.comImpediMed Reaches Milestone of 500,000 Patient Tests Performed with the SOZO Digital Health PlatformOctober 26, 2022 | finance.yahoo.comCurrent Data Support Early Detection and Intervention to Reduce Rates of Breast Cancer-Related LymphedemaOctober 20, 2022 | finance.yahoo.comNew Data Confirms Early Detection and Intervention of Lymphedema Improves Quality of Life for Breast Cancer Patients Who Avoid Chronic LymphedemaOctober 11, 2022 | finance.yahoo.comImpediMed Expands Use of SOZO in Leading Cancer Centers Focused on Reducing the Impact of Lymphedema after Breast CancerOctober 10, 2022 | finance.yahoo.comWhen Will ImpediMed Limited (ASX:IPD) Turn A Profit?October 4, 2022 | finance.yahoo.comImpediMed Announces U.S. Launch of Lymphedema Prevention Program with GenesisCare a Global Organization Dedicated to Care of Cancer PatientsSeptember 30, 2022 | finance.yahoo.comImpediMed Announces Two Posters at Heart Failure Society of America Annual Scientific Meeting That Demonstrate Utility of SOZO® Digital Health Platform for Heart Failure PatientsSeptember 23, 2022 | reuters.comIPD.AX - Impedimed Limited | Stock Price & Latest News | ReutersAugust 30, 2022 | finance.yahoo.comWe're Not Very Worried About ImpediMed's (ASX:IPD) Cash Burn RateJuly 17, 2022 | apnews.comNew Data Evaluating ImpediMed’s SOZO® in Heart Failure Patients to be Presented at Heart Failure Society of America Annual Scientific Meeting 2022July 15, 2022 | finance.yahoo.comNew Data Evaluating ImpediMed's SOZO® in Heart Failure Patients to be Presented at Heart Failure Society of America Annual Scientific Meeting 2022March 18, 2022 | msn.comASX Health Stocks: ImpediMed extends SOZO contract with global pharma AstraZenecaMarch 7, 2022 | finance.yahoo.comNew Bone Data Showing Strong Correlation between ImpediMed's SOZO and DXA in Cancer Patients Presented at 39th Annual Miami Breast Cancer ConferenceFebruary 23, 2022 | finance.yahoo.comWe Think ImpediMed (ASX:IPD) Can Afford To Drive Business GrowthFebruary 15, 2022 | finance.yahoo.comNew Data Evaluating ImpediMed's SOZO® Digital Health Platform to Assess Bone in Cancer Patients to be Presented at 39th Annual Miami Breast Cancer ConferenceFebruary 1, 2022 | finance.yahoo.comNew Data Show Statistically Significant Reduction in Chronic Cancer-Related Lymphedema with Early Detection Using ImpediMed's L-Dex® Technology and InterventionJanuary 10, 2022 | finance.yahoo.comImpediMed (ASX:IPD) investors are sitting on a loss of 80% if they invested five years agoNovember 28, 2021 | news.yahoo.comAsk SCORE: How can I build a strong brand for my business?November 24, 2021 | finance.yahoo.comImpediMed Limited's (ASX:IPD) Intrinsic Value Is Potentially 32% Above Its Share PriceOctober 27, 2021 | msn.comImpedimed (ASX:IPD) share price dips following capital raising update Get ImpediMed News Delivered to You Automatically Sign up to receive the latest news and ratings for IPD and its competitors with MarketBeat's FREE daily newsletter. Email Address The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm. Click here to access the Crypto Retirement Blueprint now. IPD Media Mentions By Week IPD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IPD News Sentiment▼1.330.42▲Average Medical News Sentiment IPD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IPD Articles This Week▼30▲IPD Articles Average Week Get ImpediMed News Delivered to You Automatically Sign up to receive the latest news and ratings for IPD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cell MedX News Cochlear News Evome Medical Technologies News GN Store Nord A/S News Hamilton Thorne News Heart Test Laboratories News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:IPD) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceBiden Nomination CANCELED?The Freeport SocietyUrgent Nvidia WarningAltimetryShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImpediMed Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.